FINWIRES · TerminalLIVE
FINWIRES

FDA Proposes to Exclude Semaglutide, Tirzepatide, Liraglutide From 503B Bulks List

By

Price: $42.47, Change: $+2.18, Percent Change: +5.40%

Related Articles